UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
10-Q
(Mark
One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended March 31, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from ______ to ______
Commission
File Number: 001-41963
VOCODIA
HOLDINGS CORP
(Exact
Name of Registrant as Specified in its Charter)
Wyoming | | 86-3519415 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
36401 Congress Avenue, Suite #160, Boca
Raton, Florida 33487 | | 33487 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s
telephone number, including area code: (561) 484-5234
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, par value $0.001 per share | | VHAI | | CBOE BZX Exchange, Inc. |
Series A Warrants | | VHAI+A | | CBOE BZX Exchange, Inc. |
Series B Warrants | | VHAI+B | | CBOE BZX Exchange, Inc. |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ | | |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate
by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☒ No ☐
As of May 20, 2024, the registrant had 56,501,381 shares of common
stock, $0.0001 par value per share, outstanding.
Table
of Contents
PART
I—FINANCIAL INFORMATION
Vocodia Holdings Corp
Condensed Consolidated Balance Sheets
| |
March 31, | | |
December 31, | |
| |
2024 | | |
2023 | |
ASSETS | |
| | | |
| | |
Current Assets | |
| | | |
| | |
Cash and cash equivalents | |
$ | 2,696,858 | | |
$ | - | |
Prepaid expenses and other current assets | |
| 321,234 | | |
| 12,770 | |
Total Current Assets | |
| 3,018,092 | | |
| 12,770 | |
| |
| | | |
| | |
Non-Current Assets | |
| | | |
| | |
Property and equipment, net | |
| 21,787 | | |
| 23,267 | |
Right-of-use assets | |
| 291,621 | | |
| 316,310 | |
Deferred offering costs | |
| - | | |
| 4,085,726 | |
Other assets | |
| 21,273 | | |
| 21,273 | |
Total Non-Current Assets | |
| 334,681 | | |
| 4,446,576 | |
| |
| | | |
| | |
TOTAL ASSETS | |
$ | 3,352,773 | | |
$ | 4,459,346 | |
| |
| | | |
| | |
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | |
| | | |
| | |
Current Liabilities | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 2,090,578 | | |
$ | 2,058,533 | |
Contract liabilities | |
| 15,950 | | |
| 15,950 | |
Related party payable | |
| 76,368 | | |
| 76,368 | |
Note payable | |
| - | | |
| 25,000 | |
Convertible notes payable, net | |
| - | | |
| 3,688,566 | |
Derivative liability | |
| - | | |
| 1,922,879 | |
Operating lease liability, current portion | |
| 106,833 | | |
| 106,833 | |
Total Current Liabilities | |
| 2,289,729 | | |
| 7,894,129 | |
| |
| | | |
| | |
Non-current Liability | |
| | | |
| | |
Operating lease liability, less current portion | |
| 206,986 | | |
| 232,787 | |
Total Non-Current Liability | |
| 206,986 | | |
| 232,787 | |
TOTAL LIABILITIES | |
| 2,496,715 | | |
| 8,126,916 | |
| |
| | | |
| | |
Shareholders’ Equity (Deficit) | |
| | | |
| | |
Preferred stock, $0.0001 par value; 24,000,000 shares authorized; | |
| | | |
| | |
Series A Preferred Stock, 4,000,000 shares designated, $0.0001 par value; 4,000,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | |
| 400 | | |
| 400 | |
Series B Preferred Stock, 3,000 shares designated, $0.0001 par value; 0 and 1,305 shares issued and outstanding, as of March 31, 2024 and December 31, 2023, respectively | |
| - | | |
| - | |
Common stock, $0.0001 par value: 476,000,000 shares authorized; 17,191,993 and 4,234,747 shares issued and outstanding, as of March 31, 2024 and December 31, 2023, respectively | |
| 1,719 | | |
| 423 | |
Additional paid-in capital | |
| 98,307,479 | | |
| 86,839,777 | |
Accumulated deficit | |
| (97,453,540 | ) | |
| (90,508,170 | ) |
Total shareholders’ equity (deficit) | |
| 856,058 | | |
| (3,667,570 | ) |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | |
$ | 3,352,773 | | |
$ | 4,459,346 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
Vocodia
Holdings Corp
Condensed Consolidated Statements of Operations
| |
Three Months Ended | |
| |
March 31, | |
| |
2024 | | |
2023 | |
| |
| | |
| |
Sales, net | |
$ | - | | |
$ | 243,200 | |
Cost of Sales | |
| - | | |
| 160,223 | |
Gross profit | |
| - | | |
| 82,977 | |
| |
| | | |
| | |
Operating Expenses | |
| | | |
| | |
General and administrative expenses | |
| 1,646,902 | | |
| 308,613 | |
Salaries and wages | |
| 382,383 | | |
| 1,400,664 | |
Research and development and other service providers | |
| 793,175 | | |
| 722,436 | |
Total Operating Expenses | |
| 2,822,460 | | |
| 2,431,713 | |
| |
| | | |
| | |
Operating Loss | |
| (2,822,460 | ) | |
| (2,348,736 | ) |
| |
| | | |
| | |
Other Income (Expense) | |
| | | |
| | |
Other income | |
| - | | |
| - | |
Change in fair value of derivative liability | |
| 115,296 | | |
| 15,787 | |
Loss on settlement of debt | |
| (3,824,936 | ) | |
| - | |
Interest expense | |
| (413,270 | ) | |
| (592,017 | ) |
Total Other Income (Expense) | |
| (4,122,910 | ) | |
| (576,230 | ) |
| |
| | | |
| | |
Loss Before Taxes | |
| (6,945,370 | ) | |
| (2,924,966 | ) |
| |
| | | |
| | |
Income Taxes | |
| - | | |
| - | |
Net Loss | |
$ | (6,945,370 | ) | |
$ | (2,924,966 | ) |
| |
| | | |
| | |
Basic and diluted loss per common share | |
$ | (0.37 | ) | |
$ | (0.80 | ) |
Weighted average number of common shares outstanding - basic and diluted | |
| 18,539,389 | | |
| 3,661,744 | |
The accompanying notes are an integral part
of these condensed consolidated financial statements.
Vocodia
Holdings Corp
Condensed Consolidated Statements of Stockholders’
Equity (Deficit)
For
the Three Months Ended March 31, 2024
| |
Series
A Preferred Stock | | |
Series
B Preferred Stock | | |
Common
Stock | | |
Additional Paid-In | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Total | |
Balance,
January 1, 2024 | |
| 4,000,000 | | |
$ | 400 | | |
| 1,305 | | |
$ | - | | |
| 4,234,747 | | |
$ | 423 | | |
| 86,839,777 | | |
$ | (90,508,170 | ) | |
$ | (3,667,570 | ) |
Issuance of Series
B Preferred Stock | |
| - | | |
| - | | |
| 605 | | |
| - | | |
| - | | |
| - | | |
| 605,000 | | |
| - | | |
| 605,000 | |
Common stock
units issued for cash | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,400,000 | | |
| 140 | | |
| 5,372,647 | | |
| - | | |
| 5,372,787 | |
Deferred offering
costs | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (4,110,101 | ) | |
| - | | |
| (4,110,101 | ) |
Issuance common
stock for settlement of debt | |
| - | | |
| - | | |
| - | | |
| - | | |
| 143,262 | | |
| 15 | | |
| 286,793 | | |
| - | | |
| 286,808 | |
Common stock
issued for conversion of debt | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,801,880 | | |
| 180 | | |
| 7,657,810 | | |
| - | | |
| 7,657,990 | |
Common stock
issued for conversion of Series B Preferred Stock | |
| - | | |
| - | | |
| (1,910 | ) | |
| - | | |
| 691,404 | | |
| 69 | | |
| (69 | ) | |
| - | | |
| - | |
Common stock
issued for exercise of warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| 8,920,700 | | |
| 892 | | |
| (892 | ) | |
| - | | |
| - | |
Series C warrant
issued | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,503,514 | | |
| - | | |
| 1,503,514 | |
Stock based compensation | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 153,000 | | |
| - | | |
| 153,000 | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (6,945,570 | ) | |
| (6,945,370 | ) |
Balance,
March 31, 2024 | |
| 4,000,000 | | |
$ | 400 | | |
| - | | |
$ | - | | |
| 17,191,993 | | |
$ | 1,719 | | |
| 98,307,479 | | |
$ | (97,453,540 | ) | |
$ | 856,058 | |
For the Three Months Ended March 31, 2023
| |
Series
A Preferred
Stock | | |
Series
B Preferred
Stock | | |
Common
Stock | | |
Additional
Paid-In | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Total | |
Balance, January
1, 2023 | |
| 4,000,000 | | |
$ | 400 | | |
| - | | |
$ | - | | |
| 3,094,054 | | |
$ | 309 | | |
| 83,434,035 | | |
$ | (81,796,967 | ) | |
$ | 1,637,777 | |
Issuance
of common stock and warrants for non-employee services | |
| - | | |
| - | | |
| - | | |
| - | | |
| 158,193 | | |
| 18 | | |
| 501,989 | | |
| - | | |
| 502,007 | |
Employee
common stock compensation | |
| - | | |
| - | | |
| - | | |
| - | | |
| 600,000 | | |
| 60 | | |
| 917,940 | | |
| - | | |
| 918,000 | |
Common
stock cancelled | |
| - | | |
| - | | |
| - | | |
| - | | |
| (162,500 | ) | |
| (16 | ) | |
| 16 | | |
| - | | |
| - | |
Issuance
of Series B Preferred Stock | |
| - | | |
| - | | |
| 155 | | |
| - | | |
| - | | |
| - | | |
| 155,000 | | |
| - | | |
| 155,000 | |
Issuance
common stock for settlement of debt | |
| - | | |
| - | | |
| - | | |
| - | | |
| 25,000 | | |
| 3 | | |
| 38,247 | | |
| - | | |
| 38,250 | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (2,924,966 | ) | |
| (2,924,966 | ) |
Balance,
March 31, 2023 | |
| 4,000,000 | | |
$ | 400 | | |
| 155 | | |
$ | - | | |
| 3,714,747 | | |
$ | 374 | | |
| 85,047,227 | | |
$ | (84,721,933 | ) | |
$ | 326,068 | |
The
accompanying notes are an integral part of these condensed consolidated financial statements.
Vocodia
Holdings Corp
Condensed Consolidated Statements of Cash Flows
| |
Three Months Ended | |
| |
March 31, | |
| |
2024 | | |
2023 | |
Operating activities: | |
| | |
| |
Net Loss | |
$ | (6,945,370 | ) | |
$ | (2,924,966 | ) |
Adjustments to reconcile net loss to cash used in operating activities: | |
| | | |
| | |
Depreciation | |
| 1,480 | | |
| 1,480 | |
Amortization of debt issuance costs | |
| 165,082 | | |
| 577,793 | |
Stock-based compensation | |
| 153,000 | | |
| 1,420,007 | |
Convertible note default penalty | |
| 146,054 | | |
| - | |
Change in fair value of derivative liability | |
| (115,296 | ) | |
| (15,787 | ) |
Loss on settlement of debt | |
| 3,824,936 | | |
| | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses and other assets | |
| (308,464 | ) | |
| 108,552 | |
Accounts payable and accrued expenses | |
| 651,120 | | |
| 197,057 | |
Contract liability | |
| - | | |
| (203,000 | ) |
Net change in operating right-of-use lease asset and liability | |
| (1,112 | ) | |
| (1,085 | ) |
Cash used in operating activities | |
| (2,428,570 | ) | |
| (839,949 | ) |
| |
| | | |
| | |
Financing activities: | |
| | | |
| | |
Proceeds from issuance of common stock units | |
| 5,372,787 | | |
| - | |
Deferred offering costs | |
| (24,375 | ) | |
| (2,533 | ) |
Proceeds from issuance of Series B Preferred stock | |
| 605,000 | | |
| 155,000 | |
Proceeds from related party payable | |
| - | | |
| 65,598 | |
Proceeds from notes payable | |
| 30,000 | | |
| - | |
Repayment of notes payable | |
| (55,000 | ) | |
| - | |
Repayment of convertible notes payable | |
| (802,984 | ) | |
| - | |
Cash provided by financing activities | |
| 5,125,428 | | |
| 218,065 | |
| |
| | | |
| | |
Change in cash and cash equivalents | |
| 2,696,858 | | |
| (621,884 | ) |
Cash and cash equivalents, beginning balances | |
| - | | |
| 697,626 | |
Cash and cash equivalents, ending balances | |
$ | 2,696,858 | | |
$ | 75,742 | |
| |
| | | |
| | |
Supplemental cash flow information: | |
| | | |
| | |
Cash paid for interest | |
$ | 109,088 | | |
$ | - | |
Cash paid for taxes | |
$ | - | | |
$ | - | |
| |
| | | |
| | |
Non-Cash Investing and Financing Activities: | |
| | | |
| | |
Initial derivative liabilities recognized as a debt discount | |
$ | - | | |
$ | 505,227 | |
Common stock cancellation | |
$ | - | | |
$ | 16 | |
Series C warrant issued | |
$ | 1,053,514 | | |
$ | - | |
Issuance common stock for settlement of debt | |
$ | 286,808 | | |
$ | - | |
Common stock issued for conversion of debt | |
$ | 7,657,990 | | |
$ | - | |
Common stock issued for conversion of Series B Preferred Shares | |
$ | 69 | | |
$ | - | |
Common stock issued for exercise of warrants | |
$ | 892 | | |
$ | - | |
Common stock issued for settlement of legal fees for offering costs | |
$ | - | | |
$ | 38,250 | |
Issuance common stock for services -related party, restricted stock awards (‘RSA”) | |
$ | - | | |
$ | 183,600 | |
The accompanying notes are an integral part
of these condensed consolidated financial statements.
VOCODIA
HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
1 – ORGANIZATION AND GOING CONCERN
Organization
and Business Overview
The
Company and Business: Vocodia Holdings Corp (“we”, “us”, “Vocodia”, “the Company”) was
incorporated in the State of Wyoming on April 27, 2021 and is a conversational artificial intelligence (“AI”) technology
provider. Vocodia’s technology is used to increase sales and drive conversions for its product or service.
Click
Fish Media, Inc. (“CFM”) was incorporated in the State of Florida on November 29, 2019 and is an IT services provider.
On
August 2, 2022, Vocodia purchased all outstanding shares of CFM held by an owner under common ownership for $10 in consideration.
The Company determined that the acquisition met the requirements for accounting for the transaction as a transfer of an asset in accordance
with Accounting Standards Codification (“ASC”) 805-50, common control transactions and is accounted for by Vocodia at the
carrying value of the net assets transferred on a prospective basis. The transfer was not determined to be significant to the accounting
and operations of Vocodia.
Going
Concern
The Company’s condensed consolidated financial statements are
prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States including the assumption
of a going concern basis, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
However, as shown in the accompanying condensed consolidated financial statements, the Company had a net loss of approximately $6.9 million,
an accumulated deficit of approximately $97.5 million, and used cash in operations of approximately $2.4 million for the three months
ended March 31, 2024 and working capital of $728,000. In February 2024, the Company completed an Initial Public Offering (“IPO”)
of its securities in which it raised $5,950,000 in gross proceeds, before underwriting fees and expenses. The Company expects to
continue to incur significant expenditures to develop its technology. As such, there is substantial doubt about the company’s ability
to continue as a going concern.
Management
recognizes that the Company must obtain additional resources to successfully develop its technology and implement its business plans.
Through March 31, 2024, the Company has received funding in the form of indebtedness, from the sale stock subscriptions and the sale
of units in its IPO. Management may continue to raise funds to support our operations in 2024 and beyond, however it has no plans to
do so at this time. No assurances can be given that we will be successful. If management is not able to timely and successfully raise
additional capital if necessary, the implementation of the Company’s business plan, financial condition and results of operations
will be materially affected. These condensed consolidated financial statements do not include any adjustments relating to the recoverability
and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to
continue as a going concern.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03
of Regulation S-X. They do not include all information and notes required by GAAP for complete financial statements. However, except
as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements
included in the Annual Report on Form 10-K of Vocodia Holdings Corp for the year ended December 31, 2023.
In
the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been
included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be
expected for the year ending December 31, 2024.
Basis
of Consolidation
The
financial statements have been prepared on a consolidated basis with those of the Company’s wholly owned subsidiaries, Vocodia
FL, LLC, Vocodia JV, LLC, and CFM. All intercompany transactions and balances have been eliminated in consolidation.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates
and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from
these good faith estimates and judgments Significant estimates are contained in the accompanying financial statements for the valuation
of derivatives, the valuation allowance on deferred tax assets, share-based compensation, useful lives for depreciation and amortization
of long-lived assets, and the incremental borrowing rate used on right-of-use asset.
Cash
and Cash Equivalents
Cash
and cash equivalents include cash in bank accounts and money market funds with maturities of less than three months from inception, which
are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss
in value. At March 31, 2024 and December 31, 2023, the Company did not have any cash equivalents.
Periodically,
the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000 per institution.
The amount in excess of the FDIC insurance as of March 31, 2024 was approximately $2.4 million. The Company has not experienced losses
on these accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to
these deposits is not significant.
Revenue
Recognition
The
Company recognizes revenue in an amount that reflects the consideration to which it expects to be entitled in exchange for the transfer
of promised goods or services to customers. The Company follows a five-step process to achieve this core principle: (1) identify the
contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate
the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance
obligation.
The
Company’s revenues are currently derived from three sources: (1) implementation fees, (2) offering its software as a service on
a recurring monthly basis, and (3) generation and verification of leads. Implementation fees are charged for setting up or calibrating
its software so that the AI can be used by the customer for its particular use case and are usually a one-time cost. The Company’s
contracts with customers are structured with stated prices per service performed, which are not subject to uncertainty or probability
of significant reversal; thus, do not represent variable consideration. The recurring monthly fees are charged for the ongoing use of
the AI to continue to call/prospect for the Company’s customers, and are charged on a monthly recurring basis. The Company awards
discounts to its customers on a discretionary basis. The Company will consider additional revenue streams as its technology develops
and new opportunities present.
Fair
Value of Financial Instruments
The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as of the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:
| ● | Level
1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments. |
| | |
| ● | Level
2: Quoted prices for similar instruments that are directly or indirectly observable in the
marketplace. |
| | |
| ● | Level
3: Significant unobservable inputs which are supported by little or no market activity and
that are financial instruments whose values are determined using pricing models, discounted
cash flow methodologies, or similar techniques, as well as instruments for which the determination
of fair value requires a significant judgment or estimation. |
Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety
requires the Company to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or
estimation methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial
amounts recorded, may not be indicative of the amount that the Company or holders of the instruments could realize in a current market
exchange.
The
carrying amounts of the Company’s financial instruments including cash and cash equivalents, prepaid expenses, accounts payable,
accrued liabilities and convertible debt approximate fair value due to the short-term maturities of these instruments.
Set
out below are the Company’s financial instruments that are required to be remeasured at fair value on a recurring basis and their
fair value hierarchy as of December 31, 2023 (none for March 31, 2024):
December 31, 2023 | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Carrying Value | |
Liabilities: | |
| | |
| | |
| | |
| |
Derivative Liability – Warrants | |
$ | - | | |
$ | - | | |
$ | 1,698,135 | | |
$ | 1,698,135 | |
Derivative Liability – Conversion feature | |
| - | | |
| - | | |
| 224,744 | | |
| 224,744 | |
Total Liabilities | |
$ | - | | |
$ | - | | |
$ | 1,922,879 | | |
$ | 1,922,879 | |
Deferred
Offering Costs
Pursuant
to ASC 340-10-S99-1, costs directly attributable to an offering of equity securities are deferred and would be charged against the gross
proceeds of the offering as a reduction of additional paid-in capital. Deferred offering costs consist of underwriting, legal, accounting,
and other expenses incurred through the balance sheet date that are directly related to the proposed public offering. Should the proposed
public offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be expensed.
As
of March 31, 2024 and December 31, 2023, deferred offering costs consisted of the following:
| |
March
31,
2024 | | |
December 31,
2023 | |
General and administrative cash expenses | |
$ | - | | |
$ | 153,976 | |
Share-based equity compensation | |
| - | | |
| 3,931,750 | |
Total | |
$ | - | | |
$ | 4,085,726 | |
For the three months ended March 31, 2024, the
Company recognized additional expenses of $24,375 and recorded $4,110,101 of deferred offering costs as a reduction to additional paid
in capital, upon completion of the IPO.
Advertising
The
Company expenses advertising costs as they are incurred. Advertising expenses for the three months ended March 31, 2024 and 2023, were
$125,909 and $14,624, respectively.
Warrants
The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s
specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”)
and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial
instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements
for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether
the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control,
among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the
time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair
value of the warrants was estimated using a Black-Scholes pricing model.
Net
Income (Loss) Per Share of Common Stock
Net
loss per share of common stock requires presentation of basic earnings per share on the face of the statements of operations for all
entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic earnings per share
computation. In the accompanying financial statements, basic loss per share is computed by dividing net loss by the weighted average
number of shares of common stock outstanding during the year. Diluted earnings per share is computed by dividing net income by the weighted
average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the
potential dilution that could occur from common shares issuable through contingent share arrangements, warrants unless the result would
be antidilutive.
The Company includes in basic earnings per share,
common stock that is issuable for the conversion of warrants for little or no cash upon the satisfaction of certain contingent conditions.
The Company has determined that the Series B and C warrants meet these conditions as of March 31, 2024, and have included 27,135,600 (11,033,180
weighted) shares of common stock as part of our basic earnings per share, for the three months ended March 31, 2024.
The
dilutive effect of restricted stock units, options and warrants subject to vesting and other share-based payment awards is calculated
using the “treasury stock method,” which assumes that the “proceeds” from the exercise of these instruments are
used to purchase common shares at the average market price for the period. The dilutive effect of convertible securities is calculated
using the “if-converted method.” Under the if-converted method, securities are assumed to be converted at the beginning of
the period, and the resulting shares of common stock are included in the denominator of the diluted calculation for the entire period
being presented.
For
the three months ended March 31, 2024 and 2023, the following common stock equivalents were excluded from the computation of diluted
net loss per share as the result of the computation was anti-dilutive.
|
|
March 31, |
|
|
March 31, |
|
|
|
2024 |
|
|
2023 |
|
|
|
Shares |
|
|
Shares |
|
Warrants |
|
|
2,071,400 |
|
|
|
461,500 |
|
Convertible notes payable |
|
|
- |
|
|
|
583,283 |
|
Total common stock equivalents |
|
|
2,071,400 |
|
|
|
1,044,783 |
|
Recent
Accounting Pronouncements
In November
2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07,
Segment Reporting Topic 280, “Segment Reporting-Improvements to Reportable Segment Disclosures”
which allows disclosure of one or more measures of segment profit or loss used by the chief operating decision maker to allocate resources
and assess performance. Additionally, the standard requires enhanced disclosures of significant segment expenses and other segment items,
as well as incremental qualitative disclosures on both an annual and interim basis. This guidance is effective for annual reporting periods
beginning after December 15, 2023, and interim reporting periods after December 15, 2024. Early adoption is permitted and retrospective
application is required for all periods presented. The Company is currently evaluating the impact of adopting this guidance on its Consolidated
Financial Statements and disclosures included within Notes to Condensed Consolidated Financial
Statements.
In
December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires
disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid.
The guidance is effective for the Company’s fiscal years beginning after February 1, 2025, with early adoption permitted. The Company
does not expect the adoption of this standard to have any material impact on its financial statements.
NOTE
3 – PROPERTY AND EQUIPMENT
As
of March 31, 2024 and December 31, 2023, property and equipment consisted of the following:
| |
March 31, | | |
December 31, | |
| |
2024 | | |
2023 | |
Furniture and Fixtures | |
$ | 27,877 | | |
$ | 27,877 | |
Computer Equipment | |
| 9,684 | | |
| 9,684 | |
Total Property and Equipment | |
| 37,561 | | |
| 37,561 | |
Less: accumulated depreciation and amortization | |
| (15,774 | ) | |
| (14,294 | ) |
Property and Equipment, net | |
$ | 21,787 | | |
$ | 23,267 | |
During the three months ended March 31, 2024 and
2023, depreciation expense relating to property and equipment was $1,480 and $1,480, respectively.
NOTE
4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Accounts
payable and accrued expenses consisted of the following at March 31, 2024 and December 31, 2023:
| |
March 31, | | |
December 31, | |
| |
2024 | | |
2023 | |
Accounts payable | |
$ | 1,484,232 | | |
$ | 1,154,685 | |
Accrued expenses | |
| 606,346 | | |
| 556,581 | |
Accrued interest | |
| - | | |
| 339,221 | |
Bank overdraft | |
| - | | |
| 8,046 | |
Accounts payable and accrued expenses | |
$ | 2,090,578 | | |
$ | 2,058,533 | |
NOTE
5 – OPERATING LEASES
We
had operating leases for our corporate offices and one short term lease for executive offices. Our corporate office lease has a remaining
lease term of thirty-two (32) months with no options to extend.
| |
Three months ended | |
| |
March 31, | |
| |
2024 | | |
2023 | |
The components of lease expense were as follows: | |
| | |
| |
Short-term lease cost | |
$ | 16,476 | | |
$ | - | |
Operating lease cost | |
| 30,069 | | |
| 30,069 | |
Total lease cost | |
$ | 46,545 | | |
$ | 30,069 | |
| |
| | | |
| | |
Supplemental cash flow information related to leases was as follows: | |
| | | |
| | |
Operating cash flows from operating leases | |
$ | 31,180 | | |
$ | 30,562 | |
| |
| | | |
| | |
Weighted-average remaining lease term - operating leases (year) | |
| 2.67 | | |
| 3.67 | |
Weighted-average discount rate — operating leases | |
| 6.50 | % | |
| 6.50 | % |
The
following table outlines maturities of our lease liabilities as of March 31, 2024:
Year ending December 31, | |
| |
2024 (excluding the three months ended March 31, 2024) | |
$ | 94,602 | |
2025 | |
| 128,362 | |
2026 | |
| 119,969 | |
Thereafter | |
| - | |
| |
| 342,933 | |
Less: Imputed interest | |
| (29,114 | ) |
Operating lease liabilities | |
$ | 313,819 | |
NOTE
6 – NOTE PAYABLE AND CONVERTIBLE NOTES PAYABLE
Note
payable
During
the year ended December 31, 2023, the Company issued note payable of $25,000 to pay professional fees and recorded it as deferred
offering cost. The Note is unsecured, due on the earlier of the completion of an IPO or February 12, 2024, and bears interest at $5,000 if
paid before December 31, 2023 or $25,000 if paid after December 31, 2023. During the three months ended March 31, 2024, the Company
recorded interest expense of $5,000. As of March 31, 2024 and December 31, 2023, accrued interest was $0 and $5,000, respectively.
In
February 2024, the Company borrowed $30,000 and repaid the note payable and accrued interest totaling $43,000.
Convertible
notes payable
During
the years ended December 31, 2023 and 2022, the Company issued $3,368,236 in original issue discount senior secured convertible notes
(together, the “Convertible Notes”). The Convertible Notes bear interest at an annualized rate of 15%, with no interest
for the first six months. The Convertible Notes mature nine (9) months after the original issue date of the Convertible Notes, whereupon
all outstanding principal and accrued interest is due to the holders of the Convertible Notes.
The
Convertible Notes include a conversion feature, whereupon a successful Initial Public Offering (“IPO”) (the “Liquidity
Event”), the Convertible Notes may be payable to the holders by the Company delivering to the holders shares of common stock equal
to the payment amount due at the date of the Liquidity Event divided by the conversion price. As defined in the agreement, the conversion
price is the product of the offering price per share of common stock paid in a Liquidity Event and a 35% discount.
In
connection with the issuance of the Convertible Notes, the Company issued common stock purchase warrants to the holders of the Convertible
Notes (the “Warrants”). The Warrants give the holders the right, but not the obligation, to purchase shares of the Company
obtained by dividing 50% of the original principal amount of the Convertible Notes by the offering price per share of common stock
paid in a Liquidity Event. The exercise price of the Warrants are equal to the product of the conversion price of the Convertible Notes
and 120%. The Warrants expire five (5) years from the consummation of the first Liquidity Event.
The
conversion feature and Warrants have been accounted for as a derivative liability, in accordance with ASC 815 (see Note 7).
During January 2024, the Company modified outstanding
2022 Original Issue Discount Convertible Notes with original principal and accrued interest, by agreeing to certain penalties, to extend
the maturity dates until February 28, 2024. The Company determined the modifications to be debt extinguishment. As a result of the
debt extinguishment, the Company recognized a loss on settlement of debt of $1,387,314.
During February 2024, the Company modified certain
2023 Original Issue Discount Convertible Notes with original principal and accrued interest, to extend the maturity dates until February
28, 2024. The Company determined these to be a modification.
In February 2024, on completion of the IPO, all outstanding 2023 and
2022 Original Issue Discount Convertible Notes with original principal and accrued interest have been settled. In connection with settlements,
the Company paid $894,072 and issued 1,801,880 shares of common stock, value at $7,657,990, to holders of such notes, as a result
the Company recognized a loss on settlement of debt of $2,662,842. In addition, the Company issued 495,076 warrants, which immediately
upon issuance at IPO were modified to Series C warrants and were classified as equity. The Company recognized a gain on settlement of
derivative liability of $225,220, recognized as a settlement of debt.
Prior to the modifications and settlements in
January and February 2024, the Company recognized a gain on change in fair value of derivative liability for the convertible debt of
$145,895 and a loss on change of derivative liability for the warrants of $30,599.
Convertible
notes payable, net consisted of the following:
| |
| | |
Stated | | |
Effective | | |
| | |
| |
| |
Maturities | | |
Interest | | |
Interest | | |
March 31, | | |
December 31, | |
| |
(calendar year) | | |
Rate | | |
Rate | | |
2024 | | |
2023 | |
August 2022 issuances | |
| 2023 | | |
| 20 | % | |
| 195 | % | |
$ | - | | |
$ | 614,118 | |
September 2022 issuances | |
| 2023 | | |
| 20 | % | |
| 201 | % | |
| - | | |
| 1,598,824 | |
November 2022 issuances | |
| 2023 | | |
| 20 | % | |
| 212 | % | |
| - | | |
| 423,529 | |
December 2022 issuances | |
| 2023 | | |
| 20 | % | |
| 155 | % | |
| - | | |
| 276,000 | |
April 2023 issuances | |
| 2024 | | |
| 15 | % | |
| 215 | % | |
| - | | |
| 588,235 | |
May 2023 issuances | |
| 2024 | | |
| 15 | % | |
| 172 | % | |
| - | | |
| 58,824 | |
June 2023 issuances | |
| 2024 | | |
| 15 | % | |
| 170 | % | |
| - | | |
| 294,118 | |
Total face value | |
| | | |
| | | |
| | | |
| - | | |
| 3,853,648 | |
Unamortized debt discount and issuance costs | |
| | | |
| | | |
| | | |
| - | | |
| (165,082 | ) |
Total convertible notes | |
| | | |
| | | |
| | | |
| - | | |
| 3,688,566 | |
Current portion of convertible notes | |
| | | |
| | | |
| | | |
| - | | |
| (3,688,566 | ) |
Long-term convertible notes | |
| | | |
| | | |
| | | |
$ | - | | |
$ | - | |
During the three months ended March 31, 2024 and 2023, the Company
recorded interest expense of $89,133 and $13,342, respectively, which included amortization of debt discount of $165,082 and
$577,793, respectively, default penalty of $146,054 and $0, respectively. As of March 31, 2024 and December 31, 2023, accrued interest
was $0 and $339,221, respectively.
NOTE
7 – DERIVATIVE LIABILITITES
Fair
Value Assumptions Used in Accounting for Derivative Liabilities
ASC
815 requires us to assess the fair market value of derivative liabilities at the end of each reporting period and recognize any change
in the fair market value as other income or expense. The Company determined our derivative liabilities to be a Level 3 fair value measurement
and used the Black-Scholes pricing model to calculate the fair value as of issuance and at the IPO settlement date of February 26, 2024
The
Black-Scholes model, which requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate,
the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could
produce a significantly higher or lower fair value measurement. The current stock price is based on historical issuances. Expected volatility
is based on the historical stock price volatility of comparable companies’ common stock, as our stock does not have sufficient
historical trading activity. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods.
The
following table summarizes the changes in the derivative liabilities during the three months ended March 31, 2024:
|
|
2024 |
|
Expected exercise price |
|
$ |
3.32 - 8.50 |
|
Expected conversion price |
|
|
2.76 |
|
Expected term |
|
|
0.30 - 5.00 years |
|
Expected average volatility |
|
|
80 - 108 |
% |
Expected dividend yield |
|
|
- |
|
Risk-free interest rate |
|
|
4.33 – 5.46 |
% |
For
the year ended March 31, 2024 and December 31, 2023, the estimated fair values of the liabilities measured on a recurring basis are as
follows:
Fair Value Measurements Using Significant Unobservable Inputs (Level 3) |
Balance - December 31, 2023 | |
$ | 1,922,879 | |
Settlement of derivative liability from conversion of debt | |
| (78,849 | ) |
Settlement of derivative liability of warrants to Series C warrants | |
| (1,728,734 | ) |
Change in fair value of the derivative | |
| (115,296 | ) |
Balance - March 31, 2024 | |
$ | - | |
NOTE
8 – STOCKHOLDERS’ EQUITY
The Company has authorized 476,000,000 shares
of common stock with a par value of $0.0001 per share and 24,000,000 shares of Preferred Stock with a par value of $0.0001 per
share. The Company shall have the authority to issue the shares of Preferred Stock in one or more series with such rights, preferences
and designations as determined by the Board of Directors of the Company.
Series A Preferred Stock
The Company has designated 4,000,000 preferred
shares, par value $0.0001, as Series A Preferred Stock. Initially, holders of Series A Preferred Stock would have the right to vote with 1,000 votes
per common share on any matters brought before the stockholders of the Company. On April 17, 2023, our Board passed a resolution, in accordance
with the laws of the State of Wyoming which, when the SEC declares our registration statement effective, shall require the Company to
amend the rights of all authorized, issued, outstanding, and forthcoming Series A Preferred Stock, so that the holders of the Series A
Preferred Stock have no right to vote on any matters brought before the stockholders of the Company. The removal of the voting rights
became effective when the SEC declared our Registration Statement on Form S-1 effective on February 14, 2024.
The Series A Preferred Stockholders are not entitled
to any dividends, or mandatory conversion right or liquidation preference, however, they do have a voluntary conversion right.
Holders of the Company’s Series A Preferred
Stock shall have the right to convert at a ratio of 0.025 share of the Company’s common stock for 1 share of the Company’s
Series A Preferred Stock (subject to adjustments relating to stock splits, distributions, mergers, consolidation, exchange of shares,
recapitalization, reorganization, or other similar event). "Conversion Period" shall mean the period commencing on the earlier
of (i) six months after the SEC declares the Company's Registration Statement on Form S-1 No. 333-269489 effective and (ii) the first
anniversary of this unanimous written consent and ending on the fifth anniversary of this unanimous written consent.
As of March 31, 2024 and December 31, 2023, 4,000,000 shares
of Series A Preferred Stock were issued and outstanding, respectively.
Series B Preferred Stock
Effective September 27, 2023, the Company has
amended the certificate of designation to authorize 3,000 preferred shares, par value $0.0001, as Series B Preferred Stock.
Series B Preferred Stock has no voting rights, but shall be mandatorily converted into common stock with voting rights upon the completion
of our initial public offering or our change of control. The Series B Preferred Stockholders are not entitled to any dividends.
In January 2024, the Company issued an aggregate
of 605 shares of our Series B Preferred Stock to several individuals for $605,000. In February 2024, 1,910 shares of Series
B Preferred Stock were converted into 691,404 shares of common stock upon the closing of the IPO.
As of March 31, 2024 and December 31, 2023, 0
and 1,305 shares of Series B Preferred Stock were issued and outstanding, respectively.
Common Stock
Each share of Common Stock entitles the holder
to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.
During the three months ended March 31, 2024,
the Company had the following common stock transactions:
| ● | 1,400,000
units, consisting of 1 common share, 1 Series A Warrant and 1 Series B Warrant, at a price of $4.25 per unit for gross proceeds of $5,950,000,
from the IPO. After underwriting fees and discounts the net proceeds to the Company amounted to $5,324,000. |
| ● | 143,262 shares issued for settlement to related
and unrelated parties for accounts payable, valued at $286,808. Amounts settled to related parties were $77,095 (38,404 shares) to our
CEO, $95,165 (47,584 shares) to our Chief Product Officer, and $21,250 (10,625 shares) to a company owned by our CFO. |
| ● | 1,801,880
shares issued, with a fair value of $7,657,990, for settlement of convertible notes and accrued interest. |
| ● | 8,920,700 shares issued for the cashless exercise of 651,929 warrants. |
As of March 31, 2024 and December 31, 2023, 17,191,993 and 4,234,747 shares
of common stock were issued and outstanding, respectively.
For the three months ended March 31, 2024, the
Company recognized additional expenses of $24,375 and recorded $4,110,101 of deferred offering costs as a reduction to additional paid
in capital, upon completion of the IPO.
NOTE 9 – STOCK-BASED COMPENSATION
During the three months ended March 31, 2024 and
2023, stock-based compensation was recognized as follows:
| |
March 31, | | |
March 31, | |
| |
2024 | | |
2023 | |
Salaries and wages | |
$ | - | | |
$ | 918,000 | |
Research and development and other service providers | |
| - | | |
| 502,007 | |
Professional fees – restricted stock awards | |
| 153,000 | | |
| - | |
| |
$ | 153,000 | | |
$ | 1,420,007 | |
Warrants
During the three months ended March 31, 2024,
the Company issued warrants as follows;
| ● | 1,609,900 series A warrants with exercise price
of $5.5250 and the term of 5 years |
| | |
| ● | 1,610,000 series B warrants with exercise price
of $8.50 and the term of 5 years |
| | |
| ● | 495,076 Series C warrants with exercise price
of $8.50 and the term of 5 years |
A summary of activity of the warrants during the
year ended March 31, 2024, are as follows:
| |
Warrants Outstanding | | |
Weighted
Average | |
| |
Number of | | |
Weighted
Average | | |
Remaining life | |
| |
Warrants | | |
Exercise Price | | |
(years) | |
Outstanding, January1, 2023
| |
| 361,500 | | |
$ | 5.62 | | |
| 3.41 | |
Granted | |
| 100,000 | | |
| 1.00 | | |
| 3.00 | |
Expired / cancelled | |
| - | | |
| - | | |
| - | |
Exercised | |
| - | | |
| - | | |
| - | |
Outstanding, December 31, 2023 | |
| 461,500 | | |
$ | 6.63 | | |
| 2.58 | |
Granted | |
| 3,714,976 | | |
| 7.21 | | |
| 5.00 | |
Expired / cancelled | |
| - | | |
| - | | |
| - | |
Exercised | |
| (651,929 | ) | |
| 8.50 | | |
| - | |
Outstanding, March 31, 2024 | |
| 3,524,547 | | |
$ | 6.63 | | |
| 4.53 | |
The intrinsic value of the warrants as of March 31, 2024 is $0. All
of the outstanding warrants are exercisable as of March 31, 2024.
2022 Equity Compensation Plan
On November 9, 2023, the Company’s stockholders
approved the 2022 Equity Compensation Plan, or the 2022 Plan. The 2022 Plan provides that grants may be in any of the following forms:
incentive stock options, nonqualified stock options, stock units, stock awards, dividend equivalents and other stock-based awards. The
2022 Plan is administered and interpreted by the Compensation Committee of the Board of Directors, or the Committee. The Committee has
the authority to determine the individuals to whom grants will be made under the 2022 Plan, determine the type, size and terms of the
grants, determine the time when grants will be made and the duration of any applicable exercise or restriction period (subject to the
limitations of the 2022 Plan) and deal with any other matters arising under the 2022 Plan. The Committee presently consists of three directors,
each of whom is a non-employee director of the Company. All the employees of the Company and its subsidiaries are eligible for grants
under the 2022 Plan. Non-employee directors of the Company are also eligible to receive grants under the 2022 Plan.
Restricted Stock Awards
On November 2, 2023, the Company issued 120,000 restricted
stock awards (“RSAs”) representing 120,000 shares of common stock to EverAsia Financial Group. Inc, a company owned
by our Chief Financial Officer. RSAs issued in connection with the 2022 Plan shall be subject to a twelve-month vesting period, whereas 10,000 shares
shall vest upon the first of every month. However, should the Company successfully complete an initial public offering of its common shares
on any stock exchange in the United States of America, 100% of the then unvested RSAs shall immediately vest upon the completion
of the IPO.
During the three months ended March 31, 2024 and
2023, the Company recorded stock-based compensation of $153,000 and $0, respectively, related to the issuance of RSAs. As of March
31, 2024 and December 31, 2023, there was $0 and $153,000 of total unrecognized expense related to non-vested awards of RSAs. The
cost was fully recognized, due to the Company’s IPO being effective on February 23, 2024.
The following summary reflects changes in the
shares of Common Stock Restricted Stock Awards (RSA):
Unvested Outstanding at December 31, 2023 | |
| 100,000 | | |
$ | 1.53 | | |
| 153,000 | |
Granted | |
| - | | |
| | | |
| - | |
Vested /Released | |
| (100,000 | ) | |
| 1.53 | | |
| (153,000 | ) |
Cancelled | |
| - | | |
| | | |
| | |
Unvested Outstanding at March 31, 2024 | |
| - | | |
$ | - | | |
| - | |
NOTE
10 – RELATED PARTY TRANSACTIONS
Operating
expense related party
During the three months ended March 31, 2024 and 2023, the Company
incurred approximately $30,000 and $222,500, respectively, in investor marketing and relations services from a company owned by the
former chief strategy officer.
Related
party payable
On August 1, 2022, the Company entered into a lending arrangement with
a related party, the prior owner of Click Fish Media. The loan is for a two (2) year term and accrued simple annual interest at a rate
of 5% per annum. As of March 31, 2024 and December 31, 2023, the remaining note payable balance was $76,368 and $76,368, respectively,
which includes all outstanding principle and accrued interest.
Related
party management fees
During
the three months ended March 31, 2024 and 2023, 47 Capital Management LLC, an entity wholly owned by the former CFO billed the Company
$0 and $35,630 and the Company paid $5,000 and $35,630, respectively. 47 Capital Management LLC provided outsourced CFO
services.
During
the three months ended March 31, 2024 and 2023, EverAsia Financial Group, Inc., an entity majority owned by the CFO, billed the Company $110,000 and
$0, respectively and the Company paid $110,000 and $0 respectively. EverAsia Financial Group provided financial consulting
services from May, 2023 through October, 2023. From November 2023 through December, 2023, EverAsia Financial Group, Inc. provided outsourced
CFO services.
Related party debt conversion to common
stock
In January 2024, 38,404 shares, valued at $2.00
per share, for a total value of $77,095 were issued to our CEO for settlement to related parties for accounts payable.
In January 2024, 47,584 shares, valued at $2.00
per share, for a total value of $95,165 were issued to our Chief Product Officer for settlement to related parties for accounts payable
In January 2024, 10,625 shares, valued at $2.00
per share, for a total value of $21,250 were issued to a company owned by our CFO for settlement to related parties for accounts payable
NOTE
11 – COMMITMENTS AND CONTINGENCIES
From
time to time, we may be involved in various disputes and litigation matters that arise in the ordinary course of business.
The
Company received a letter dated August 28, 2023, from an attorney hired on behalf of a former employee of the Company. This former employee
offered her resignation, which was accepted on July 12, 2023. This letter contains allegations that the former employee was sexually
harassed and terminated wrongfully by the Company. The Company is of the opinion that allegations in this letter lack merit. The Company
has reported this matter to its insurance carrier and outside counsel has been engaged. The Company denies liability and intends to continue
to vigorously defend any action, although the probability of a favorable or unfavorable outcome is difficult to estimate as of this date.
The result or impact of such allegations are uncertain, including whether or not they could result in damages and/or awards of attorneys’
fees or expenses. In December 2023 the former employee’s attorney requested that the parties attend mediation, however a date for
said mediation has not been determined. Due to the uncertain outcome of the case, no amounts have been accrued.
NOTE
12 – SUBSEQUENT EVENTS
In April and May 20, 2024 Company issued
39,309,388 shares of common stock for the cashless exercise of 320,559 warrants.
Management evaluated all additional events subsequent
to the balance sheet date through May 20, 2024, the date the condensed consolidated financial statements were available to be issued.
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated
financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q. Our consolidated financial statements
have been prepared in accordance with U.S. GAAP. In addition, our consolidated financial statements and the financial data included in
this Quarterly Report on Form 10-Q K reflect our reorganization and have been prepared as if our current corporate structure had been
in place throughout the relevant periods. Actual results could differ materially from those projected in the forward-looking statements.
For additional information regarding these and other risks and uncertainties, please see the items listed above under the section captioned
“Risk Factors”, as well as any other cautionary language contained in this Quarterly Report on Form 10-Q. Except as may be
required by law, we undertake no obligation to update any forward-looking statements to reflect events after the date of this Quarterly
Report on Form 10-Q.
CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains certain “forward-looking statements” within the meaning of Section 27A of the
Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). These forward-looking statements represent our expectations, beliefs, intentions, or strategies concerning
future events, including, but not limited to, any statements regarding our assumptions about financial performance; the continuation
of historical trends; growth strategies; the sufficiency of our cash balances for future liquidity and capital resource needs; the expected
impact of changes in accounting policies on our results of operations, financial condition or cash flows; anticipated problems and our
plans for future operations; our future financing plans and anticipated needs for working capital; and the economy in general or the
future of the food production industry, all of which were subject to various risks and uncertainties. Such statements, when used in this
Annual Report on Form 10-K and other reports, statements, and information we have filed with the Securities and Exchange Commission (“SEC”),
in our press releases, presentations to securities analysts or investors, in oral statements made by or with the approval of an executive
officer, are generally identifiable by use of the words “may,” “will,” “should,” “expect,”
“anticipate,” “continue,” “estimate,” “believe,” “intend,” or “project”
or the negative of these words or other variations on these words or comparable terminology. However, any statements contained in this
Annual Report on Form 10-K that are not statements of historical fact may be deemed to be forward-looking statements. These statements
are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be
achieved or accomplished.
This
information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or
achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking
statements. These statements may be found under Part I Item 1 “Business” and Part II Item 7 “Management’s
Discussion and Analysis of Financial Condition and Results of Operations,” as well as in other parts of this Quarterly Report
on Form 10-Q. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various
factors as described in this Quarterly Report on Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance
that the forward-looking statements contained in this Quarterly Report on Form 10-Q will in fact occur. In addition to the information
expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to ensure
that the required statements, in light of the circumstances under which they are made, are not misleading.
Although
forward-looking statements in this Quarterly Report on Form 10-Q reflect the good faith judgment of our management, forward-looking statements
are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results
to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on
these forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. We assume no obligation to update
any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report on
Form 10-Q, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various
disclosures made by us in our reports filed with the Securities and Exchange Commission (“SEC”) which attempt to advise interested
parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more
of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially
from those expected or projected.
This
Quarterly Report on Form 10-Q also contains estimates, projections, and other information concerning our industry, our business, and
particular markets, including data regarding the estimated size of those markets. Information that is based on estimates, forecasts,
projections, market research, or similar methodologies is inherently subject to uncertainties and actual events or circumstances may
differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry,
business, market, and other data from reports, research surveys, studies, and similar data prepared by market research firms and other
third parties, industry, general publications, government data, and similar sources.
Overview
Vocodia
Holdings Corp (“VHC”) was incorporated in the State of Wyoming on April 27, 2021 and is a conversational AI technology provider.
Vocodia’s technology is designed to drive better sales and services for its customers. Clients turn to Vocodia for their product
and service needs.
Business
Summary
We
are an AI software company that builds practical AI functions and makes them easily obtainable for businesses on cloud-based platform
solutions at low costs and scalable to multiagent vast enterprise solutions.
Our
operations include three wholly owned subsidiaries: (1) Vocodia FL, which was incorporated in the State of Florida on June 2, 2021 and
manages all of VHC’s human resources and payroll functions, (2) Vocodia JV, which was incorporated in the State of Delaware on
October 7, 2021 and was formed with the intention to conduct any and all joint ventures or acquisitions for VHC, which do not exist as
of the date of this report, and (3) Click Fish Media, Inc. (“CFM”), which was incorporated in the State of Florida on November
26, 2019 and is an IT services provider. CFM was formerly owned by James Sposato, who is an officer and director of the Company. CFM
was wholly acquired by the Company from Mr. Sposato per the Contribution Agreement. CFM was formerly owned by James Sposato, who is an
officer and director of the Company. CFM was acquired by us from Mr. Sposato per the Contribution Agreement, dated August 1, 2022. In
the Contribution Agreement, Mr. Sposato (“Contributor”), has contributed, assigned, transferred and delivered to us, the
outstanding capital stock of CFM and we have accepted the contributed shares from the Contributor. As full consideration for the contribution,
we have paid the Contributor consideration in the amount of $10.
An illustration
of our organizational structure is provided below:
We
aim to offer corporate clients scalable enterprise AI sales and customer service solutions intended to rapidly increase sales and service,
while lowering employment costs.
We
seek to enhance rapport and relationship building for customers, which is as necessary component to sales. We believe that there is a
positive correlation between AI which sounds similar to a human voice over the phone and better customer rapport and customer service
benefits. With our advanced AI, we believe that it will be difficult for customers to distinguish between speaking to a human sales representative
and to an AI bot. We believe we can increase customer satisfaction and maximize potential service efficiency for our clients. Our goal
is to provide quick training and deployment, potentially unlimited scalability, easy integration with existing corporate platforms and
other benefits to our customers from AI’s efficiency. We strive to help our customers manage budgets and perform better than the
high costs of existing sales and service personnel.
On
February 26, 2024, we completed our initial public offering (the “IPO”) of 1,400,000 units, each consisting of one share
of common stock, par value $0.0001 (“Common Stock”), one Series A Warrant to purchase one share of Common Stock at $4.25 (the
“Series A Warrant”), and one Series B Warrant to purchase one share of Common Stock at $8.50 (the “Series B Warrant”),
at a price to the public of $4.25 per Unit.
The
gross proceeds from the IPO, before underwriting discounts and commissions and estimated offering expenses payable by us, were approximately
$5,950,000. On February 22, 2024, our Common Stock, Series A Warrants and Series B Warrants began trading on the BZX Exchange, a division
of Cboe Global Markets, under the ticker symbols “VHAI,” “VHAI+A” and “VHAI+B”, respectively.
Results
of Operations
Comparison
of the three months ended March 31, 2024 to the three months ended March 31, 2023
The
following tables set forth selected consolidated statements of operations data and such data as a percentage of total revenues for each
of the periods indicated:
| |
Three Months Ended | | |
| | |
| |
| |
March 31, | | |
March 31, | | |
| | |
| |
| |
2024 | | |
2023 | | |
Change | | |
% | |
Revenues | |
$ | - | | |
$ | 243,200 | | |
| (243,200 | ) | |
| -100 | % |
Cost of revenue | |
| - | | |
| 160,223 | | |
| (160,223 | ) | |
| -100 | % |
Gross profit (loss) | |
| - | | |
| 82,977 | | |
| (82,977 | ) | |
| -100 | % |
| |
| | | |
| | | |
| | | |
| | |
Operating costs and expenses: | |
| | | |
| | | |
| | | |
| | |
Operating expense | |
| 2,822,460 | | |
| 2,431,713 | | |
| 390,747 | | |
| 16 | % |
| |
| | | |
| | | |
| | | |
| | |
Other income (expenses) | |
| (4,122,910 | ) | |
| (576,230 | ) | |
| (3,546,680 | ) | |
| 615 | % |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (6,945,370 | ) | |
$ | (2,924,966 | ) | |
| (4,020,404 | ) | |
| 137 | % |
Revenue
Revenue decreased by 100%, or $243,200, to $0 for the three months
ended March 31, 2024 as compared to $243,200 for the three months ended March 31, 2023. Beginning in January 2024, we suspended sales
of our DISA product in order to update its functionality so it could scale to the needs of our customers. As a result, we also did not
earn any revenue from integration, lead generation, and setup fees. We anticipate launching our improved DISA product in the second quarter
of 2024. For the three months ended March 31, 2023, we had 1 paying client who subscribed to 10 DISAs at a selling price of $795 per DISA
for one month for total revenue of $7,950 for the period. Additionally, we earned $235,250 in integration, lead generation, and setup
fees, resulting in total revenue of $243,200.
Cost
of Revenue
Cost of revenue decreased by $160,223, or 100%, to $0 for the three
months ended March 31, 2024 from $160,223 for the three months ended March 31, 2023, primarily due to the reduction of costs related to
the deployment of our DISAs.
Gross
profit (loss)
The decrease in our gross profit of $82,977 to a gross loss of $0 for
the three months ended March 31, 2024 from a gross profit of $82,977 for the three months ended March 31, 2023 is primarily attributable
to the suspension of DISA sales during the first quarter.
Operating
Expenses
| |
Three Months Ended | | |
| | |
| |
| |
March 31, | | |
March 31, | | |
| | |
| |
| |
2024 | | |
2023 | | |
Change | | |
% | |
Operating Expenses | |
| | |
| | |
| | |
| |
General and administrative expenses | |
$ | 1,646,902 | | |
$ | 308,613 | | |
| 1,338,289 | | |
| 434 | % |
Salaries and wages | |
| 382,383 | | |
| 1,400,664 | | |
| (1,018,281 | ) | |
| -73 | % |
Software development and other service providers | |
| 793,175 | | |
| 722,436 | | |
| 70,739 | | |
| 10 | % |
Total Operating Expenses | |
$ | 2,822,460 | | |
$ | 2,431,713 | | |
| 390,747 | | |
| 16 | % |
Operating expense increased by $390,747 or 16%
to $2,822,460 for the three months ended March 31, 2024 from $2,431,713 for the three months ended March 31, 2023 is primarily due to
the increase in general and administrative expenses related to our initial public offering and software development costs related to improving
our DISA products and a reduction in stock based compensation expenses paid to employees and service providers.
General and Administrative Expenses increased
by $ 1,338,289 or 434% to $1,646,902 during the three months ended March 31, 2024 from $308,613 during the three months ended March 31,
2023. The increase is primarily a result of the Company’s increased costs related to the IPO and of being a public company related
to insurance, professional fees, and investor relations.
Salaries and wages expense decreased by $1,018,281,
or 73%, to $382,383 for the three months ended March 31, 2024 from $1,400,664 for the three months ended March 31, 2023, due to a reduction
in staff in 2024 and a reduction in stock based compensation paid.
Research and development and other service providers
expense increased by $ 70,739, or 10%, to $793,175 the three months ended March 31, 2024 from $ 722,436 for the three months ended March
31, 2023, primarily related to accelerated investments in developing our next-generation AI-powered virtual agent platform, We are also
incurring considerable data labeling expenses as we scale out language model training across multiple domains, industries and languages,
which is essential for our virtual agents to provide highly contextualized and personalized customer experiences. Finally, we are developing
advanced multimodal AI capabilities that we anticipate will intelligently interpret voice and text during customer interactions.
Total
other income (expense)
During the three months ended March 31, 2024,
we had other expense of $4,122,910, which consisted of a change in fair value of derivative liabilities of $ 115,296, a loss on the settlement
of debt of $3,824,936 and interest expense of $413,270.
Liquidity
and Capital Resources
The
following table provides selected financial data about us as of March 31, 2024 and December 31, 2023
| |
March 31, | | |
December 31, | | |
| | |
| |
| |
2024 | | |
2023 | | |
Change | | |
% | |
Current assets | |
$ | 3,018,092 | | |
$ | 12,770 | | |
$ | 3,005,322 | | |
| 23,534 | % |
Current liabilities | |
$ | 2,289,729 | | |
$ | 7,894,129 | | |
$ | (5,604,400 | ) | |
| -71 | % |
Working capital (deficiency) | |
$ | 728,363 | | |
$ | (7,881,359 | ) | |
$ | 8,609,722 | | |
| -109 | % |
Current assets increased by $3,005,322, or 23,534%, to $3,018,092 as
of March 31, 2024 from $12,770 as of December 31, 2023. The increase was primarily attributable to the sale of 1,400,000 units, comprised
of 1,400,000 shares of common stock, Series A Warrants and Series B Warrants in our initial public offering at $4.25 per unit, for gross
proceeds of $5,950,000 before underwriter fees and discounts.
Current liabilities decreased by $5,604,400, or
71%, to $2,289,729 as of March 31, 2024 from $7,894,129 as of December 31, 2023. The decrease was primarily attributable to conversion
and settlement of approximately $3.7 million in convertible notes and associated $1.9 million in derivative liabilities subsequent to
our initial public offering.
We
believe we will not have sufficient cash on hand to support our operations for at least 12 months. As of March 31, 2024, we had working
capital of approximately $728,000 and total cash of approximately $2.7 million. As discussed below, this condition and other factors
raise substantial doubt regarding our ability to continue as a going concern.
We
intend to generally rely on cash from operations and equity and debt offerings to the extent necessary and available, to satisfy our
liquidity needs. There are several factors that could result in the need to raise additional funds, including a decline in revenue, a
lack of anticipated sales growth and increased costs. Our efforts are directed toward generating positive cash flow and, ultimately,
profitability. As our efforts during our fiscal 2023 and since have not generated positive cash flows, we will need to raise additional
capital. Should capital not be available to us at reasonable terms, other actions will become necessary, including implementing cost
control measures and additional efforts to increase sales. We may also be required to take more strategic actions such as exploring strategic
options for the sale of our company, the creation of joint ventures or strategic alliances under which we will pursue business opportunities,
or other alternatives.
Cash
Flow
| |
Three months Ended | | |
| |
| |
March 31, | | |
| |
| |
2024 | | |
2023 | | |
Change | |
Cash used in operating activities | |
$ | (2,428,570 | ) | |
$ | (839,949 | ) | |
$ | (1,588,621 | ) |
Cash used in investing activities | |
$ | - | | |
$ | - | | |
$ | - | |
Cash provided by financing activities | |
$ | 5,125,428 | | |
$ | 218,065 | | |
$ | 4,907,363 | |
Cash on hand | |
$ | 2,696,858 | | |
$ | 75,742 | | |
$ | 2,621,116 | |
Cash
Flow from Operating Activities
Three
months ended March 31, 2024 and 2023
For the three months ended March 31, 2024 and
2023, we did not generate positive cash flows from operating activities. For the three months ended March 31, 2024, net cash flows used
in operating activities was $2,428,570 compared to $839,949 during the three months ended March 31, 2023.
Cash flows used in operating activities for the
three months ended March 31, 2024 was comprised of a net loss of $6,945,370, which was reduced by non-cash expenses of $4,175,256 for
stock-based compensation, depreciation and amortization, convertible notes default penalties, and change in fair value of derivative liabilities,
and net change in working capital of $341,544.
For
the three months ended March 31, 2023, net cash flows used in operating activities was $839,949. During the three months ended March
31, 2023, we had a net loss of $2,924,966, which was reduced by non-cash expenses of $1,983,493 for stock-based compensation, depreciation
and amortization, convertible notes default penalties, and change in fair value of derivative liabilities, and net change in working
capital of $101,524.
Cash
Flows from Financing Activities
During the three months ended March 31, 2024,
cash provided by financing activities of $5,125,428 included $5,372,787 from the sales of common stock units, $605,000 from the sale of
605 Preferred B shares, and $30,000 from the issuance of note payable, and was offset by deferred offering costs of $24,375 and the repayment
of notes payable of $55,000 and convertible notes payable of $802,984. During the three months ended March 31, 2023, net cash provided
by financing activities of $218,065 included proceeds of $155,000 from the sale of 155 Preferred B shares and proceeds from related party
notes payable of $65,598 and was offset by deferred offering costs of $2,533.
Off-Balance
Sheet Arrangements
We
do not have any off-balance sheet arrangements or relationships with unconsolidated entities or financial partnerships, such as entities
often referred to as structured finance or special purpose entities.
Going
Concern
The
accompanying financial statements of the Company are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates
realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated
financial statements are issued.
In
accordance with Financial Accounting Standards Board (“FASB”), Accounting Standards Update (“ASU”) No. 2014-15,
Presentation of Financial Statements – Going Concern (Subtopic 205-40), the Company’s management evaluates whether there
are conditions or events, considered in aggregate, that raise substantial doubt about the Company’s ability to continue as a going
concern within one year after the date that the accompanying financial statements are issued.
Critical
Accounting Policies
Our
accounting policies are more fully described in our unaudited financial statements. The preparation of financial statements in conformity
with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Although these estimates are based on our best knowledge of
current and anticipated events, actual results could differ from the estimates.
We
have identified the following accounting policies as those that require significant judgments, assumptions and estimates and that have
a significant impact on our financial condition and results of operations. These policies are considered critical because they may result
in fluctuations in our reported results from period to period, due to the significant judgments, estimates and assumptions about complex
and inherently uncertain matters and because the use of different judgments, assumptions or estimates could have a material impact on
our financial condition or results of operations. We evaluate our critical accounting estimates and judgments required by our policies
on an ongoing basis and update them as appropriate based on changing conditions.
Fair
Value of Financial Instruments. The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”)
ASC 820, Fair Value Measurements. ASC 820 provides a framework for measuring fair value and requires disclosures regarding fair value
measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal,
most advantageous market for the specific asset or liability.
The
Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring
basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement.
The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining
fair value.
The
three tiers are defined as follows:
| ● | Level 1 – Observable inputs that reflect quoted market prices (unadjusted) for identical
assets or liabilities in active markets; |
| ● | Level 2
– Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the
marketplace for identical or similar assets and liabilities; and |
| ● | Level 3
– Unobservable inputs that are supported by little or no market data, which require the Company to develop its own
assumptions. |
The
determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations
often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation
methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the
asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions
of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors
to assist us in determining fair value, as appropriate.
Derivative
Liabilities. The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No.
480, (“ASC 480”), “Distinguishing Liabilities from Equity” and FASB ASC Topic No. 815, (“ASC 815”)
“Derivatives and Hedging”. Derivative liabilities are adjusted to reflect fair value at each reporting period, with
any increase or decrease in the fair value recorded in the results of operations (other income/expense) as change in fair value of derivative
liabilities. The Company uses a binomial pricing model to determine fair value of these instruments.
Beneficial
Conversion Features. For instruments that are not considered liabilities under ASC 480 or ASC 815, the Company applies ASC 470-20
to convertible securities with beneficial conversion features that must be settled in stock. ASC 470-20 requires that the beneficial
conversion feature be valued at the commitment date as the difference between the effective conversion price and the fair market value
of the common stock (whereby the conversion price is lower than the fair market value) into which the security is convertible, multiplied
by the number of shares into which the security is convertible limited to the amount of the loan. This amount is recorded as a debt discount
and amortized to interest expense in the Consolidated Statements of Operations.
Debt
Discount. For certain notes issued, the Company may provide the debt holder with an original issue discount. The original issue discount
is recorded as a debt discount, reducing the face amount of the note, and is amortized to interest expense over the life of the debt,
in the Consolidated Statements of Operations.
Research
and Development. The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development
(“ASC 730-10”).
Under
ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development
costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or
as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related
to both present and future products are expensed in the period incurred.
Stock-based
Compensation. The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation”
using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award
and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting
for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an
entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments
or that may be settled by the issuance of those equity instruments.
The
Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the
fair value of options.
The
fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services
is completed (measurement date) and is recognized over the vesting periods.
When
determining fair value, the Company considers the following assumptions in the Black-Scholes model:
|
● |
Exercise price, |
|
|
|
|
● |
Expected dividends, |
|
|
|
|
● |
Expected volatility, |
|
|
|
|
● |
Risk-free interest rate; and |
|
|
|
|
● |
Expected life of option |
Recent
Accounting Standards. Changes to accounting principles are established by the FASB in the form of Accounting Standards Updates (“ASU’s”)
to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our financial position, results of operations,
stockholders’ deficit, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued
by the FASB in the form of Accounting Standards Updates (“ASU”) through the date these financial statements were available
to be issued and found the following recent accounting pronouncements issued, but not yet effective accounting pronouncements, are not
expected to have a material impact on the financial statements of the Company.
In
August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”),
as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or
improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes
from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component,
unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium.
As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and
will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method
when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current
accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning
after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the
fiscal year.
We
do not expect the adoption of this pronouncement will have a material effect on our financial statements.
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a “smaller
reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.
ITEM 4. CONTROLS AND PROCEDURES
As a public company, we will be subject to the
reporting requirements of the Exchange Act, and the Sarbanes-Oxley Act. We expect that the requirements of these rules and regulations
will continue to increase our legal, accounting and financial compliance costs, make some activities more difficult, time consuming and
costly, and place significant strain on our personnel, systems and resources.
The Sarbanes-Oxley Act requires, among other things,
that we maintain effective disclosure controls and procedures, and internal control over financial reporting.
We do not yet have effective disclosure controls
and procedures, or internal controls over all aspects of our financial reporting. We are continuing to develop and refine our disclosure
controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we will
file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Our management
has deemed certain conditions to be material weaknesses and significant deficiencies in our internal controls. For example, we failed
to employ a sufficient number of staff to maintain optimal segregation of duties and to provide optimal levels of oversight and we rely
upon a third-party accounting firm to assist us with generally accepted in the United States of America (“GAAP”) compliance.
Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as defined in Rule 13a-15(f)
under the Exchange Act. We will be required to expend time and resources to further improve our internal controls over financial reporting,
including by expanding our staff. However, we cannot assure you that our internal control over financial reporting, as modified, will
enable us to identify or avoid material weaknesses in the future.
Our current controls and any new controls that
we develop may become inadequate because of changes in conditions in our business, including increased complexity resulting from our international
expansion. Further, weaknesses in our disclosure controls or our internal control over financial reporting may be discovered in the future.
Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation or improvement, could harm
our operating results or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements
for prior periods. Any failure to implement and maintain effective internal control over financial reporting could also adversely affect
the results of management reports and independent registered public accounting firm audits of our internal control over financial reporting
that we will eventually be required to include in our periodic reports that will be filed with the SEC. Ineffective disclosure controls
and procedures, and internal control over financial reporting could also cause investors to lose confidence in our reported financial
and other information, which would likely have a negative effect on the market price of our common stock.
We are not currently required to comply with the
SEC rules that implement Section 404 of the Sarbanes-Oxley Act, and are therefore not required to make a formal assessment of the
effectiveness of our internal control over financial reporting for that purpose. As a public company, we will be required to provide an
annual management report on the effectiveness of our internal control over financial reporting commencing with our second annual report
on Form 10-K. Our independent registered public accounting firm is not required to audit the effectiveness of our internal control
over financial reporting until after we are no longer an “emerging growth company” as defined in the JOBS Act. At such time,
our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at
which our internal control over financial reporting is documented, designed or operating.
PART
II—OTHER INFORMATION
Item 1.
Legal Proceedings.
We
may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.
The
Company received a letter dated August 28, 2023, from an attorney hired on behalf of a former employee of the Company. This former employee
offered her resignation, which was accepted on July 12, 2023. This letter contains allegations that the former employee was sexually
harassed and terminated wrongfully by the Company. The Company is of the opinion that allegations in this letter lack merit. The former
employee recently filed a charge with the Equal Employment Opportunity Commission and the Fair Employment Practices Agencies (EEOC/FEPA)
alleging discrimination based on sex and retaliation, among other specific allegations including disparate impact/intent and/or treatment
and discrimination/harassment/retaliation based on being a female. She also claims she was subjected to a sexually hostile environment.
The Company has reported this matter to its insurance carrier and outside counsel has been engaged. The Company’s counsel filed a position
statement with the EEOC in response to the filed charge. The Company denies liability and intends to continue to vigorously defend any
action, although the probability of a favorable or unfavorable outcome is difficult to estimate as of this date. The result or impact
of such allegations are uncertain, including whether or not they could result in damages and/or awards of attorneys’ fees or expenses.
Item 1A.
Risk Factors.
We are a
smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.
You should
carefully consider the risk factors discussed in our Annual Report on Form 10-K under the heading “Part I, Item 1A. Risk Factors,”
which risks could materially affect our business, financial condition or future results. Such risks are not the only risks facing the
Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, also may have a material
adverse effect on our business, financial condition and future results or enhance the adverse impact of the risks known to us.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3.
Defaults Upon Senior Securities.
[None]
Item 4.
Mine Safety Disclosures.
Not applicable.
Item 5.
Other Information.
Subsequent
Events
[*]
Item 6.
Exhibits.
Furnish
the exhibits required by Item 601 of Regulation S-K (§ 229.601 of this chapter).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
VOCODIA
HOLDINGS CORP |
|
|
|
Date:
May 20, 2024 |
By: |
/s/
Brian Podolak |
|
|
Brian
Podolak |
|
|
Chief
Executive Officer |
|
|
(Principal
Executive Officer) |
|
|
|
Date:
May 20, 2024 |
By: |
/s/
Scott J. Silverman |
|
|
Scott
J. Silverman |
|
|
(Principal
Financial and Accounting Officer) |
26
0.37
0.80
18539389
3661744
P5Y
false
--12-31
Q1
0001880431
0001880431
2024-01-01
2024-03-31
0001880431
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001880431
vhai:SeriesAWarrantsMember
2024-01-01
2024-03-31
0001880431
vhai:SeriesBWarrantsMember
2024-01-01
2024-03-31
0001880431
2024-05-20
0001880431
2024-03-31
0001880431
2023-12-31
0001880431
us-gaap:RelatedPartyMember
2024-03-31
0001880431
us-gaap:RelatedPartyMember
2023-12-31
0001880431
us-gaap:SeriesAPreferredStockMember
2024-03-31
0001880431
us-gaap:SeriesAPreferredStockMember
2023-12-31
0001880431
us-gaap:SeriesBPreferredStockMember
2024-03-31
0001880431
us-gaap:SeriesBPreferredStockMember
2023-12-31
0001880431
2023-01-01
2023-03-31
0001880431
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-12-31
0001880431
us-gaap:CommonStockMember
2023-12-31
0001880431
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001880431
us-gaap:RetainedEarningsMember
2023-12-31
0001880431
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-03-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-03-31
0001880431
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001880431
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001880431
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001880431
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2024-03-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2024-03-31
0001880431
us-gaap:CommonStockMember
2024-03-31
0001880431
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001880431
us-gaap:RetainedEarningsMember
2024-03-31
0001880431
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2022-12-31
0001880431
us-gaap:CommonStockMember
2022-12-31
0001880431
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001880431
us-gaap:RetainedEarningsMember
2022-12-31
0001880431
2022-12-31
0001880431
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-03-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-03-31
0001880431
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001880431
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001880431
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001880431
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2023-03-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2023-03-31
0001880431
us-gaap:CommonStockMember
2023-03-31
0001880431
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001880431
us-gaap:RetainedEarningsMember
2023-03-31
0001880431
2023-03-31
0001880431
vhai:ClickFishMediaMember
2022-08-02
2022-08-02
0001880431
2024-02-29
2024-02-29
0001880431
vhai:SeriesBWarrantsMember
2024-01-01
2024-03-31
0001880431
vhai:SeriesCWarrantsMember
2024-01-01
2024-03-31
0001880431
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:WarrantMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:WarrantMember
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
vhai:ConversionFeatureMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
vhai:ConversionFeatureMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
vhai:ConversionFeatureMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
vhai:ConversionFeatureMember
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001880431
us-gaap:GeneralAndAdministrativeExpenseMember
2024-01-01
2024-03-31
0001880431
us-gaap:GeneralAndAdministrativeExpenseMember
2023-01-01
2023-12-31
0001880431
us-gaap:StockCompensationPlanMember
2024-01-01
2024-03-31
0001880431
us-gaap:StockCompensationPlanMember
2023-01-01
2023-12-31
0001880431
2023-01-01
2023-12-31
0001880431
us-gaap:WarrantMember
2024-01-01
2024-03-31
0001880431
us-gaap:WarrantMember
2023-01-01
2023-03-31
0001880431
us-gaap:ConvertibleDebtSecuritiesMember
2024-01-01
2024-03-31
0001880431
us-gaap:ConvertibleDebtSecuritiesMember
2023-01-01
2023-03-31
0001880431
us-gaap:FurnitureAndFixturesMember
2024-03-31
0001880431
us-gaap:FurnitureAndFixturesMember
2023-12-31
0001880431
us-gaap:ComputerEquipmentMember
2024-03-31
0001880431
us-gaap:ComputerEquipmentMember
2023-12-31
0001880431
us-gaap:NotesPayableOtherPayablesMember
2023-12-31
0001880431
us-gaap:NotesPayableOtherPayablesMember
2024-02-12
0001880431
us-gaap:NotesPayableOtherPayablesMember
2024-01-01
2024-03-31
0001880431
us-gaap:NotesPayableOtherPayablesMember
2024-03-31
0001880431
us-gaap:NotesPayableOtherPayablesMember
2024-02-29
0001880431
us-gaap:ConvertibleNotesPayableMember
2023-01-01
2023-12-31
0001880431
us-gaap:ConvertibleNotesPayableMember
2022-01-01
2022-12-31
0001880431
us-gaap:ConvertibleNotesPayableMember
2024-03-31
0001880431
us-gaap:ConvertibleNotesPayableMember
2024-01-01
2024-03-31
0001880431
us-gaap:ConvertibleNotesPayableMember
2024-01-01
2024-01-31
0001880431
us-gaap:ConvertibleNotesPayableMember
2024-02-29
0001880431
us-gaap:IPOMember
2024-03-31
0001880431
2024-02-29
0001880431
us-gaap:WarrantMember
2024-02-29
0001880431
us-gaap:ConvertibleNotesPayableMember
2023-12-31
0001880431
vhai:AugustTwoThousandTwentyTwoIssuancesMember
2023-12-31
0001880431
vhai:AugustTwoThousandTwentyTwoIssuancesMember
2024-03-31
0001880431
vhai:SeptemberTwoThousandTwentyTwoIssuancesMember
2023-12-31
0001880431
vhai:SeptemberTwoThousandTwentyTwoIssuancesMember
2024-03-31
0001880431
vhai:NovemberTwoThousandTwentyTwoIssuancesMember
2023-12-31
0001880431
vhai:NovemberTwoThousandTwentyTwoIssuancesMember
2024-03-31
0001880431
vhai:DecemberTwoThousandTwentyTwoIssuancesMember
2023-12-31
0001880431
vhai:DecemberTwoThousandTwentyTwoIssuancesMember
2024-03-31
0001880431
vhai:AprilTwoThousandTwentyThreeIssuancesMember
2023-12-31
0001880431
vhai:AprilTwoThousandTwentyThreeIssuancesMember
2024-03-31
0001880431
vhai:MayTwoThousandTwentyThreeIssuancesMember
2023-12-31
0001880431
vhai:MayTwoThousandTwentyThreeIssuancesMember
2024-03-31
0001880431
vhai:JuneTwoThousandTwentyThreeIssuancesMember
2023-12-31
0001880431
vhai:JuneTwoThousandTwentyThreeIssuancesMember
2024-03-31
0001880431
srt:MinimumMember
us-gaap:MeasurementInputExercisePriceMember
2024-03-31
0001880431
srt:MaximumMember
us-gaap:MeasurementInputExercisePriceMember
2024-03-31
0001880431
us-gaap:MeasurementInputConversionPriceMember
2024-03-31
0001880431
srt:MinimumMember
us-gaap:MeasurementInputExpectedTermMember
2024-03-31
0001880431
srt:MaximumMember
us-gaap:MeasurementInputExpectedTermMember
2024-03-31
0001880431
srt:MinimumMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-03-31
0001880431
srt:MaximumMember
us-gaap:MeasurementInputPriceVolatilityMember
2024-03-31
0001880431
us-gaap:MeasurementInputExpectedDividendRateMember
2024-03-31
0001880431
srt:MinimumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-03-31
0001880431
srt:MaximumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-03-31
0001880431
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001880431
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2024-01-01
2024-03-31
0001880431
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2024-03-31
0001880431
2023-08-31
0001880431
us-gaap:PreferredStockMember
2023-08-31
0001880431
us-gaap:SeriesAPreferredStockMember
2024-01-01
2024-03-31
0001880431
us-gaap:SeriesBPreferredStockMember
2023-09-27
0001880431
us-gaap:SeriesBPreferredStockMember
2024-01-31
2024-01-31
0001880431
us-gaap:SeriesBPreferredStockMember
us-gaap:IPOMember
2024-02-29
2024-02-29
0001880431
us-gaap:CommonStockMember
us-gaap:IPOMember
2024-02-29
2024-02-29
0001880431
us-gaap:IPOMember
2024-01-01
2024-03-31
0001880431
srt:ChiefExecutiveOfficerMember
2024-01-01
2024-03-31
0001880431
vhai:ChiefProductOfficerMember
2024-01-01
2024-03-31
0001880431
srt:ChiefFinancialOfficerMember
2024-01-01
2024-03-31
0001880431
us-gaap:WarrantMember
2024-01-01
2024-03-31
0001880431
vhai:SeriesAWarrantsMember
2024-03-31
0001880431
vhai:SeriesBWarrantsMember
2024-03-31
0001880431
vhai:SeriesCWarrantsMember
2024-03-31
0001880431
2023-11-02
2023-11-02
0001880431
us-gaap:CommonStockMember
2023-11-02
2023-11-02
0001880431
us-gaap:RestrictedStockMember
2023-11-02
2023-11-02
0001880431
us-gaap:RestrictedStockMember
2024-01-01
2024-03-31
0001880431
us-gaap:RestrictedStockMember
2023-01-01
2023-03-31
0001880431
us-gaap:RestrictedStockMember
2024-03-31
0001880431
us-gaap:RestrictedStockMember
2023-12-31
0001880431
vhai:SalariesAndWagesMember
2024-01-01
2024-03-31
0001880431
vhai:SalariesAndWagesMember
2023-01-01
2023-03-31
0001880431
us-gaap:ResearchAndDevelopmentExpenseMember
2024-01-01
2024-03-31
0001880431
us-gaap:ResearchAndDevelopmentExpenseMember
2023-01-01
2023-03-31
0001880431
vhai:ProfessionalFeesRestrictedStockAwardsMember
2024-01-01
2024-03-31
0001880431
vhai:ProfessionalFeesRestrictedStockAwardsMember
2023-01-01
2023-03-31
0001880431
us-gaap:WarrantMember
2022-12-31
0001880431
us-gaap:WarrantMember
2022-01-01
2022-12-31
0001880431
us-gaap:WarrantMember
2023-01-01
2023-12-31
0001880431
us-gaap:WarrantMember
2023-12-31
0001880431
us-gaap:WarrantMember
2024-01-01
2024-03-31
0001880431
us-gaap:WarrantMember
2024-03-31
0001880431
us-gaap:RelatedPartyMember
2024-01-01
2024-03-31
0001880431
us-gaap:RelatedPartyMember
2023-01-01
2023-03-31
0001880431
2022-08-01
0001880431
vhai:CapitalManagementLLCMember
2024-01-01
2024-03-31
0001880431
vhai:CapitalManagementLLCMember
2023-01-01
2023-03-31
0001880431
srt:ChiefFinancialOfficerMember
vhai:CapitalManagementLLCMember
2024-01-01
2024-03-31
0001880431
srt:ChiefFinancialOfficerMember
vhai:CapitalManagementLLCMember
2023-01-01
2023-03-31
0001880431
vhai:EverAsiaFinancialGroupIncMember
2024-01-01
2024-03-31
0001880431
vhai:EverAsiaFinancialGroupIncMember
2023-01-01
2023-03-31
0001880431
srt:ChiefFinancialOfficerMember
vhai:EverAsiaFinancialGroupIncMember
2024-01-01
2024-03-31
0001880431
srt:ChiefFinancialOfficerMember
vhai:EverAsiaFinancialGroupIncMember
2023-01-01
2023-03-31
0001880431
srt:ChiefExecutiveOfficerMember
2024-01-31
0001880431
srt:ChiefExecutiveOfficerMember
2024-01-31
2024-01-31
0001880431
vhai:ChiefProductOfficerMember
2024-01-31
0001880431
vhai:ChiefProductOfficerMember
2024-01-31
2024-01-31
0001880431
vhai:CFOMember
2024-01-31
0001880431
vhai:CFOMember
2024-01-31
2024-01-31
0001880431
us-gaap:CommonStockMember
us-gaap:SubsequentEventMember
2024-04-30
0001880431
us-gaap:CommonStockMember
us-gaap:SubsequentEventMember
2024-05-20
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure